As such, Wells Fargo remains highly favorable on data center real estate investment trusts, viewing colocation assets as ...

Wells Fargo’s equity research team is turning cautious on the AI trade, arguing that the constraint is no longer whether demand will grow, but whether the broader economy and available capital can ...

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic ...

Wells Fargo & Co. is the second bank to turn cautious on US stocks this week as the market heads into what is historically the worst month on the calendar for equities and upcoming midterm elections ...

Goldman Sachs, PNC and Capital One are also among 21 financial institutions partnering on an asset expected to go to market early next year.

Wells joins Morgan Stanley in halting its participation in the Forbes and Shook Research lists amid a payment controversy, ...

PG&E (PGC) is on track to close meaningfully lower on Aug. 31 after Wells Fargo downgraded the utility company to “Equal ...

Marvell gets a major Wells Fargo price-target increase just before earnings, as investors weigh whether its massive AI rally ...

Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...

Crown Legacy Wealth joins the fast-growing hybrid RIA as advisor recruitment intensifies across the wirehouse channel.

New teams from William Blair, Ameriprise and UBS bring more than $560 million in combined client assets to the firm's ...

A Hawaii appeals court ruled that holding the note - not tracing every assignment - is what gives a lender the right to ...